Public Health
Disease outbreaks, vaccines, hospital and health-system news, medical research and guidance from health authorities.
Latest Public Health stories
County Durham breast cancer failure bosses to review 4,500 more cases
Hundreds of women have been harmed by issues such as delayed diagnoses and unnecessary surgeries.
Woman dead and multiple people injured after bus collides with two cars in Victoria
Four occupants of bus taken to hospital after multi-vehicle crash in Glenburn
Research Targets Equitable Cancer Outcomes for Aussies
A $5 million Cancer Institute NSW grant is powering the next generation of researchers to help drive more equitable cancer outcomes for regional NSW
Surrey and Sussex Cancer Alliance launches HPV vaccine campaign
Surrey and Sussex Cancer Alliance says HPV vaccine uptake has yet to recover to pre-pandemic levels.
Tai Chi, Mindfulness May Help With Pain and Fatigue Following Cancer Treatment
Mindfulness-based cancer recovery and Tai Chi/Qigong improve fatigue and pain interference in patients with post-cancer treatment distress.
Numbing Creams, Breastfeeding, and Faster Shots Top New Guideline to Ease Needle Pain and Fear at Every Age
A new guideline lists 16 evidence-based ways to ease vaccine pain and fear, from breastfeeding babies to numbing creams. What families can use.
Orange County man dies after contracting West Nile virus, family says
The family of an Orange County man says he died after contracting West Nile virus and is sharing his story in hopes of warning others.
Cancer Horoscope Today: September 24, 2026
See what the stars have in store for your sign
Single-nucleus atlas of cell-type specific genetic regulation in the human brain
Genetic risk variants for common diseases are predominantly located in non-coding regulatory regions and modulate gene expression. Although bulk tissue studies have elucidated shared mechanisms of regulatory and disease-associated genetics, the cellular specificity of these mechanisms remains largely unexplored. Here we present a comprehensive, single-nucleus multi-ancestry atlas of genetic regulation of gene expression in the human prefrontal cortex, comprising 5.6 million nuclei from 1,384 don
Cheaper Cancer Drug Alternatives Slash Treatment Costs
Key takeawaysThe high cost of biologic drugs for cancer treatment can add to the financial burden of healthcare; lower-cost versions known as
Vancouver biotech Zymeworks closes US$929M Theravance deal
Theravance deal diversifies Zymeworks’ portfolio beyond cancer-focused business
'My children shouldn't have to do this': Sons' epic walk for terminally ill dad
Two sons are preparing to walk hundreds of miles across the country in a desperate bid to help their terminally ill dad access potentially life-extending cancer treatment.
Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research
PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025 and is projected to expand at a 12.1% CAGR from 2025 to 2034, reaching USD 581.2 Billion by 2034, according to a new analysis by Maximize Market Research. Global...
Octant Announces First Patient Dosed in Phase 1b/2 Clinical Study of OCT-980 for the Treatment of Retinitis Pigmentosa
EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a clinical-stage drug discovery company developing corrector therapies for protein misfolding diseases, today announced that the first patient has been dosed in its ongoing Phase 1/2 clinical study evaluating OCT-980, an investigational oral small molecule for the treatment of rhodopsin-associated autosomal dominant Retinitis Pigmentosa (RHO-adRP). RHO-adRP is an inherited retinal disease caused by mutations in the RHO gene, the most common for
What are my children exposed to? Why I want testing for cancer-causing chemicals
People living near a lagoon branded "a shame on Britain" want to be tested for cancer-causing PCBs.
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Multiple Sclerosis Treatment Market was valued at USD 26.76 Billion in 2025 and is projected to expand at a 5.8% CAGR from 2026 to 2034, reaching USD 44.45 Billion by 2034, according to a new analysis by Maximize Market Research....
Wyden Says Klomp, Under Pressure, Restarted VFC COVID Shot Access
Body: Senate Finance Committee ranking Democrat Ron Wyden (WI) took credit for HHS deputy secretary nominee Chris Klomp restarting access to COVID-19 vaccines through the Vaccines for Children program, suggesting Klomp only did so under pressure from Wyden and his staff to resolve the issue. The Centers for Disease Control and Prevention program, which provides vaccines for low-income children, was not providing COVID shots until Wednesday (Sept. 23). Despite stating Klomp had apparently resolve
CDC lists first U.S. measles death of 2026 on website, while Pennsylvania reports four deaths
The Centers for Disease Control and Prevention updated its website to note a single death from the measles so far this year, but officials in Pennsylvania have announced four measles deaths.
Oklahoma doctors highlight progress in childhood cancer treatment
During Childhood Cancer Awareness Month, experts at the Jimmy Everest Center in Oklahoma are sharing how research is improving outcomes for young cancer patients, including a near 100% cure rate for certain leukemia cases.
Maine’s first new hospital in 30 years opens in Bangor
Encompass Health Rehabilitation Hospital of Bangor is located at 1017 Union St. in Bangor.
How Info60 covers this topic
Each story below is a short excerpt from reporting by an established publisher, shown in the publisher's own words. We credit the publisher and link to the original article. Stories are matched to this topic by keyword and shown newest first.